Prednisone 10 days on/10 days off in patients with Duchenne muscular dystrophy

Journal of Neurology

Volumn 256, Issue 5, 2009, Pages 768-773

  Straathof, Chiara S M ^a   Overweg Plandsoen, W C G ^a   Van Den Burg, Gert Jan ^b   Van Der Kooi, Anneke J ^c   Verschuuren, Jan J G M ^a   De Groot, Imelda J M ^d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GELDERSE VALLEI HOSPITAL   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Muscle disorders; Muscular dystrophy

Indexed keywords

CORTICOSTEROID; DIGOXIN; PREDNISONE;

ADOLESCENT; ADRENAL INSUFFICIENCY; ARTICLE; BODY HEIGHT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG WITHDRAWAL; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; FRACTURE; HUMAN; HYPERACTIVE; HYPERTENSION; LOST AMBULATION; MALE; MOBILIZATION; NOCTURIA; OBESITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; TREATMENT DURATION; TREATMENT WITHDRAWAL; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ADOLESCENT; AGE FACTORS; AGE OF ONSET; AKATHISIA, DRUG-INDUCED; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FRACTURES, BONE; GLUCOCORTICOIDS; HUMANS; MALE; MOBILITY LIMITATION; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; OBESITY; OSTEOPOROSIS; PREDNISONE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 67349178586     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5012-y     Document Type: Article

References (26)

1. Manzur AY, Kuntzer T, Pike M, Swan A (2004) Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev 2:CD003725
2. IJ de Groot 2006 Guideline on the use of corticosteroids in Duchenne muscular dystrophy from paediatric neurologists, neurologists and rehabilitation physicians Ned Tijdschr Geneeskd 150 684 685
3. JR Mendell RT Moxley RC Griggs 1989 Randomized double blind six-month trial of prednisone in Duchenne's muscular dystrophy N Eng J Med 320 1592 1597 (Pubitemid 19154573)
4. RC Griggs RT Moxley III JR Mendell 1991 Prednisone in Duchenne dystrophy Arch Neurol 48 383 388
5. GM Fenichel JR Mendell RT Moxley III 1991 Comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy Arch Neurol 48 575 579
6. C Angelini E Pegoraro E Turella MT Intino A Pini C Costa 1994 Deflazacort in Duchenne dystrophy: study of long-term effect Muscle Nerve 17 386 391 (Pubitemid 24096533)
7. L Merlini A Cicognani E Malaspina 2003 Early prednisone treatment in Duchenne muscular dystrophy Muscle Nerve 27 222 227 (Pubitemid 36169334)
8. WD Biggar L Politano VA Harris 2004 Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols Neuromuscul Disord 14 476 482 (Pubitemid 39141702)
9. AM Connolly J Schierbecker R Renna J Florence 2002 High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy Neuromuscul Disord 12 917 925 (Pubitemid 35414370)
10. EAC Beenakker JM Fock MJ Van Tol 2005 Intermittent prednisone therapy in Duchenne muscular dystrophy Arch Neurol 62 128 132
11. A Sansome P Royston V Dubowitz 1993 Steroids in Duchenne muscular dystrophy; pilot study of a new low-dosage schedule Neuromuscul Disord 3 567 569 (Pubitemid 24050839)
12. M Kinali E Mercuri M Main F Muntoni V Dubowitz 2002 An effective, low-dosage, intermittent schedule of prednisolone in the long-term treatment of early cases of Duchenne dystrophy Neuromuscul Disord 12 S169 S174 (Pubitemid 36163354)
13. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114[Suppl 2]:555-576 (Pubitemid 39006657)
14. B Balaban DJ Matthews GH Clayton T Carry 2005 Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy. Long term effect Am J Phys Med Rehabil 84 843 850 (Pubitemid 41546724)
15. WM King HM Ruttencutter V Nagaraja 2007 Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy Neurology 68 1607 1613 (Pubitemid 46717986)
16. Pradhan S, Ghosh D, Kumar Svrivasta N et al (2006) Prednisolone in Duchenne muscular dystrophy with imminent loss of ambulation. J Neurol 253:1309-1316
17. S DeSilva DB Drachman D Mellits RW Kuncl 1987 Prednisone treatment in Duchenne muscular dystrophy Arch Neurol 44 818 822
18. Emery AEH, Muntoni F (2003) Duchenne muscular dystrophy. Oxford University Press, New York
19. M Eagle SV Baudouin C Chandler DR Giddings R Bullock K Bushby 2002 Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation Neuromuscul Disord 12 926 929 (Pubitemid 35408673)
20. JPJ Bakker IJM de Groot A Beelen GJ Lankhorst 2002 Predictive factors of cessation of ambulation in patients with Duchenne muscular dystrophy Am J Phys Med Rehabil 81 906 912 (Pubitemid 35351098)
21. JR Mendell C Csimma CM McDonald 2007 Challenges in drug development for muscle disease: a stakeholders' meeting Muscle Nerve 35 8 16 (Pubitemid 46061362)
22. MM Hoffner E Feiwel J Perry C Bonnet 1973 Functional ambulation in patients with menongomyelocele J Bone Joint Surg 55 137 145
23. EAC Beenakker NM Maurits JM Fock OF Brouwer JH van der Hoeven 2005 Functional ability and muscle force in healthy children and ambulant Duchenne muscular dystrophy patients Eur J Paediatr Neurol 9 387 393 (Pubitemid 43019593)
24. MH Brooke GM Fenichel RC Griggs 1987 Clinical investigation of Duchenne muscular dystrophy interesting results in a trial of prednisone Arch Neurol 44 812 817
25. DG McDonald M Kinali AC Gallagher 2002 Fracture prevalence in Duchenne muscular dystrophy Dev Med Child Neurol 4 695 698 (Pubitemid 35230031)
26. P Vestergaard H Glerup BF Steffensen 2001 Fracture risk in patients with muscular dystrophy and spinal muscular atrophy J Rehabil Med 33 150 155 (Pubitemid 32700475)